GL1X · GenesisL1 explorer

Research workbench

Crystal structure of V30M mutated transthyretin in complex with 4- chloro-9-oxo-9H-xanthene-2-carboxylic acid

Analyse Crystal structure of V30M mutated transthyretin in complex with 4… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7DT8
Type
protein
Length
230 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transthyretin
UniProt
P02766
Ligands
HH9, CA
Pockets
1 · best druggability 0.36

Structure

x-ray diffraction · 1 distinct chain · 6% helix, 53% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BTransthyretinprotein1156% helix, 53% strandP02766

Ligands and binding sites

  • HH9 · 4-chloranyl-9-oxidanylidene-xanthene-2-carboxylic acid · ligand · 2 copies · chains A, B
  • CA · Calcium ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1820.360.7617empty

Interfaces

1 interface between chains.

  • A–B · 952 Ų buried · 18 hydrogen bonds · protein-protein

Compared structures

  • 7DT8 · Crystal structure of V30M mutated transthyretin in complex with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.